Skip to content
PlayHub360 offers the latest gaming news, in-depth reviews,…

Users Discontinuing Slimming Jabs Put On Weight at a Quadrupled Rate Than People Using Diet and Exercise

Illustration of pharmaceutical syringe and scale
Weight management often requires ongoing approaches.

New research indicates that people who stop using popular GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who halt conventional lifestyle programs.

Findings released in a prominent medical journal demonstrates that while overweight people can lose a large proportion of their body weight while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month once they quit.

"Users using these drugs need to be informed of the risk of quick weight regain when the therapy ends," warns researcher Dr. Susan Jebb.

That rate of recovery implies a reversion to original mass in about a year and a half.

Comparing Treatments

The analysis, which examined dozens of trials involving over 9,000 of patients, compared the effects of GLP-1 agonists with other pills.

Scientists note that people who shed pounds through diet and exercise usually have a slower creep back—approximately 0.1 kg a month—after stopping.

The Reason for the Rapid Regain

Nutrition scientists suggest the mechanism of the jabs accounts for the accelerated regain.

These medications copy a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of the hormone concentrations far above than the body's typical production might result in the body to produce less of its endogenous GLP-1, and could reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.

"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making excessive eating much more probable."

A Lifelong Condition?

Health authorities advise the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.

A number of clinicians contend that, considering the likelihood of relapse, the therapy might need to be ongoing.

This perspective is echoed by pharmaceutical companies, who state that the findings "underscore the persistent character of obesity," akin to managing conditions like high blood pressure.

User Testimonies

Individuals who have stopped the jabs report a intense resurgence of appetite.

"It was like a switch activating and you become starving," described a patient.

The struggle is compounded if patients have not developed lasting dietary or behavioural changes during treatment.

Growing Use

Figures suggest that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.

  • Adoption is higher among females than males.
  • The 40s and 50s demographic shows the highest level of interest.
  • Many obtain the medications through private prescriptions rather than public health services.

In conclusion, experts caution that while the jabs are potent agents for shedding pounds, they are not a permanent cure and maintained weight loss likely depends on combined lifestyle changes.

About the author

Ronald Lara

A passionate gaming journalist with over a decade of experience covering industry trends and reviewing the latest titles across all platforms.

PlayHub360

Type to search articles.